Australian Government - Department of Health

Medical Services Advisory Committee (MSAC)

1149 - Holmium Laser Enucleation of the Prostate (HOLEP) Combined with Tissue Morcellation

Application No.

1149
Application NameHolmium Laser Enucleation of the Prostate (HOLEP) Combined with Tissue Morcellation
Description Of InterventionHolmium Laser Enucleation of the Prostate is a method of completely removing the enlarged prostate gland, via the urethra, rather than by an operation that accesses the prostate via an external incision (an open prostatectomy), or by cutting, or shaving the tissue away via the urethra. Using a cystoscope inserted via the tip of the penis and positioned in the urethra at the level of the enlarged prostate, the surgeon uses a laser fiber that emits its focussed light through the end of a very thin tube to cut through the enlarged prostate tissue. The properties of this form of laser light allow it to both ‘cut’ tissue and also ‘coagulate’ or seal bleeding vessels that are disrupted during the removal of the tissue.
Description Of DiseaseBenign Hyperplasia of the Prostate (BPH) describes the non-cancerous proliferation of tissue that causes a general enlargement of the prostate. It is a common condition with symptoms of varying degrees experienced in approximately 50% of men over the age of 50 years. The likelihood of this condition increases with age. The prostate is a gland found in males, responsible for the production of the fluid portion of seminal fluid, located at the base of the bladder. The enlargement of the prostate causes a variety of lower urinary tract symptoms that result from the compression of the urethra by the expanding prostate tissue. Untreated BPH may result in damage to the normal function of the bladder and the kidneys. While BPH is not a fatal disease, it significantly impacts on the quality of life of many middle-aged and elderly men.
Disease GroupCancer
Disease sub GroupProstate
Intervention CategoryTherapeutic
Intervention Type-
Intervention Sub Type-
Received3 August 2010
Stage 2 - Eligibility11 August 2010
Stage 3 - 1st PASC 17 February 2011
Stage 3 - Public CommentReleased for comment 24 February 2011
Closed for comments 31 March 2011
Stage 3 - 2nd PASCPASC 13-14 April
PDF version Final Decision Analytic Protocol (PDF 522 KB)
Word version Final Decision Analytic Protocol (Word 379 KB)
Stage 4 - Submission of EvidenceContracted Assessment
PDF version Assessment Report (PDF 2687 KB)
Word version Assessment Report (Word 512 KB)
Stage 5 - ESC evaluationOctober 2012
Stage 6 - MSAC AppraisalNovember 2012
Stage 6 - MSAC advicePDF version Public Summary Document (PDF 807 KB)
Word version Public Summary Document (Word 282 KB)
Stage 7 - Noting by Minister
  • advice is not communicated to the Minister until the Minutes of the relevant meeting have been ratified by MSAC members (which may take several weeks)
  • the Minister needs time to properly consider MSAC's advice (and may choose to seek further policy advice from the department before noting the advice)
  • a Government decision to list a service supported by MSAC is taken in the context of other Government priorities: MSAC's support of an application for public funding does not oblige the Government to list the service on the MBS
-
Stage 8 - ImplementationImplemented onto the MBS on 01/03/2013
MBS Item: 37245

Page currency, Latest update: 05 November, 2014